The Prospective Collection Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
-
- STATUS
- Recruiting
-
- End date
- May 2, 2024
-
- participants needed
- 2000
-
- sponsor
- Wake Forest University Health Sciences
Summary
To provide the IRB approved mechanism for the prospective collection, analysis and reporting of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach.
Details
| Condition | hodgkin, Acute Myeloid Leukemia, Myelodysplastic Syndromes (MDS), hodgkin's lymphomas, Bone marrow disorder, Immunodeficiency Diseases, Lymphoproliferative Disorder, childhood ALL, non-hodgkin's lymphoma (nhl), Multiple Myeloma, leukemia, acute lymphoblastic, acute lymphoid leukaemia, Non-Hodgkin's Lymphoma, anll, Lymphoproliferative disorders, acute lymphoblastic leukemia (all), Bone Marrow Disorder, chronic lymphocytic leukemia (cll), acute lymphocytic leukemia, myelodysplastic syndromes, Acute Myelogenous Leukemia (AML), Chronic myeloid leukemia, acute myelogenous leukemia, acute myeloblastic leukemia, leukemia chronic lymphocytic, MYELODYSPLASTIC SYNDROME, multiple myeloma (mm), Chronic Lymphocytic Leukemia, myelodysplastic syndrome (mds), chronic myelogenous leukemia, Germ cell tumor, Germ Cell Tumors, Preleukemia, Acute myeloid leukemia, hodgkin's lymphoma, Lymphocytic Leukemia, Acute, hodgkin lymphomas, small lymphocytic lymphoma, hodgkins lymphoma, Chronic Myeloid Leukemia, Hodgkin's Disease, Lymphoma, Lymphocytic Leukemia, Chronic |
|---|---|
| Clinical Study Identifier | NCT01890486 |
| Sponsor | Wake Forest University Health Sciences |
| Last Modified on | 2 December 2021 |
How to participate?
,
You have contacted , on
Your message has been sent to the study team at ,
What happens next?
- You can expect the study team to contact you via email or phone in the next few days.
- Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer